Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1

por Ettl, Johannes, Klein, Evelyn, Hapfelmeier, Alexander, Grosse Lackmann, Kirsten, Paepke, Stefan, Petry, Christoph, Specht, Katja, Wolff, Laura, Höfler, Heinz, Kiechle, Marion
Publicado 2017

Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo

por Amygdalos, Iakovos, Hachgenei, Enno, Burkl, Luisa, Vargas, David, Goßmann, Paul, Wolff, Laura I., Druzenko, Mariia, Frye, Maik, König, Niels, Schmitt, Robert H., Chrysos, Alexandros, Jöchle, Katharina, Ulmer, Tom F., Lambertz, Andreas, Knüchel-Clarke, Ruth, Neumann, Ulf P., Lang, Sven A.
Publicado 2022

Optical coherence tomography combined with convolutional neural networks can differentiate between intrahepatic cholangiocarcinoma and liver parenchyma ex vivo

por Wolff, Laura I., Hachgenei, Enno, Goßmann, Paul, Druzenko, Mariia, Frye, Maik, König, Niels, Schmitt, Robert H., Chrysos, Alexandros, Jöchle, Katharina, Truhn, Daniel, Kather, Jakob Nikolas, Lambertz, Andreas, Gaisa, Nadine T., Jonigk, Danny, Ulmer, Tom F., Neumann, Ulf P., Lang, Sven A., Amygdalos, Iakovos
Publicado 2023